Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms

Research output: Contribution to journalReview article

Abstract

Introduction: The classification of lymphomas is based on the postulated normal counterparts of lymphoid neoplasms and currently constitutes over 100 definite or provisional entities. As this number of entities implies, lymphomas show marked pathological, genetic, and clinical heterogeneity. Recent molecular findings have significantly advanced our understanding of lymphomas. Areas covered: The World Health Organization (WHO) classification of lymphoid neoplasms was updated in 2017. The present review summarizes the new findings that have been gained in the areas of mature T-cell neoplasms, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms since the publication of the 2017 WHO classification. Expert opinion: Although formal revisions to the WHO classification are published only periodically, our understanding of the pathologic, genetic, and clinical features of lymphoid neoplasms is constantly evolving, particularly in the age of –omics technologies and targeted therapeutics. Even in the relatively short time since the publication of the 2017 WHO classification, many significant findings have been identified in the entities covered in this review.

Original languageEnglish (US)
Pages (from-to)833-843
Number of pages11
JournalExpert Review of Hematology
Volume12
Issue number10
DOIs
StatePublished - Oct 3 2019

Fingerprint

T-Cell Lymphoma
Hodgkin Disease
Dendritic Cells
Lymphoma
Neoplasms
Publications
Genetic Heterogeneity
Expert Testimony
Technology
T-Lymphocytes

Keywords

  • Adult T-cell leukemia/lymphoma
  • EBV-associated T-/NK-cell neoplasms
  • genetic abnormalities
  • histiocytic/dendritic cell tumors
  • Hodgkin lymphoma
  • mature T-cell neoplasms
  • WHO classification

ASJC Scopus subject areas

  • Hematology

Cite this

Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms. / Satou, Akira; Bennani, N. Nora; Feldman, Andrew L.

In: Expert Review of Hematology, Vol. 12, No. 10, 03.10.2019, p. 833-843.

Research output: Contribution to journalReview article

@article{66520104134444a7ae999d1570f3e4d9,
title = "Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms",
abstract = "Introduction: The classification of lymphomas is based on the postulated normal counterparts of lymphoid neoplasms and currently constitutes over 100 definite or provisional entities. As this number of entities implies, lymphomas show marked pathological, genetic, and clinical heterogeneity. Recent molecular findings have significantly advanced our understanding of lymphomas. Areas covered: The World Health Organization (WHO) classification of lymphoid neoplasms was updated in 2017. The present review summarizes the new findings that have been gained in the areas of mature T-cell neoplasms, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms since the publication of the 2017 WHO classification. Expert opinion: Although formal revisions to the WHO classification are published only periodically, our understanding of the pathologic, genetic, and clinical features of lymphoid neoplasms is constantly evolving, particularly in the age of –omics technologies and targeted therapeutics. Even in the relatively short time since the publication of the 2017 WHO classification, many significant findings have been identified in the entities covered in this review.",
keywords = "Adult T-cell leukemia/lymphoma, EBV-associated T-/NK-cell neoplasms, genetic abnormalities, histiocytic/dendritic cell tumors, Hodgkin lymphoma, mature T-cell neoplasms, WHO classification",
author = "Akira Satou and Bennani, {N. Nora} and Feldman, {Andrew L.}",
year = "2019",
month = "10",
day = "3",
doi = "10.1080/17474086.2019.1647777",
language = "English (US)",
volume = "12",
pages = "833--843",
journal = "Expert Review of Hematology",
issn = "1747-4086",
publisher = "Expert Reviews Ltd.",
number = "10",

}

TY - JOUR

T1 - Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms

AU - Satou, Akira

AU - Bennani, N. Nora

AU - Feldman, Andrew L.

PY - 2019/10/3

Y1 - 2019/10/3

N2 - Introduction: The classification of lymphomas is based on the postulated normal counterparts of lymphoid neoplasms and currently constitutes over 100 definite or provisional entities. As this number of entities implies, lymphomas show marked pathological, genetic, and clinical heterogeneity. Recent molecular findings have significantly advanced our understanding of lymphomas. Areas covered: The World Health Organization (WHO) classification of lymphoid neoplasms was updated in 2017. The present review summarizes the new findings that have been gained in the areas of mature T-cell neoplasms, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms since the publication of the 2017 WHO classification. Expert opinion: Although formal revisions to the WHO classification are published only periodically, our understanding of the pathologic, genetic, and clinical features of lymphoid neoplasms is constantly evolving, particularly in the age of –omics technologies and targeted therapeutics. Even in the relatively short time since the publication of the 2017 WHO classification, many significant findings have been identified in the entities covered in this review.

AB - Introduction: The classification of lymphomas is based on the postulated normal counterparts of lymphoid neoplasms and currently constitutes over 100 definite or provisional entities. As this number of entities implies, lymphomas show marked pathological, genetic, and clinical heterogeneity. Recent molecular findings have significantly advanced our understanding of lymphomas. Areas covered: The World Health Organization (WHO) classification of lymphoid neoplasms was updated in 2017. The present review summarizes the new findings that have been gained in the areas of mature T-cell neoplasms, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms since the publication of the 2017 WHO classification. Expert opinion: Although formal revisions to the WHO classification are published only periodically, our understanding of the pathologic, genetic, and clinical features of lymphoid neoplasms is constantly evolving, particularly in the age of –omics technologies and targeted therapeutics. Even in the relatively short time since the publication of the 2017 WHO classification, many significant findings have been identified in the entities covered in this review.

KW - Adult T-cell leukemia/lymphoma

KW - EBV-associated T-/NK-cell neoplasms

KW - genetic abnormalities

KW - histiocytic/dendritic cell tumors

KW - Hodgkin lymphoma

KW - mature T-cell neoplasms

KW - WHO classification

UR - http://www.scopus.com/inward/record.url?scp=85072687089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072687089&partnerID=8YFLogxK

U2 - 10.1080/17474086.2019.1647777

DO - 10.1080/17474086.2019.1647777

M3 - Review article

C2 - 31365276

AN - SCOPUS:85072687089

VL - 12

SP - 833

EP - 843

JO - Expert Review of Hematology

JF - Expert Review of Hematology

SN - 1747-4086

IS - 10

ER -